Company profile: Alamar Biosciences
1.1 - Company Overview
Company description
- Provider of technologies enabling the earliest possible detection and treatment of cancer and other diseases.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Alamar Biosciences
Abraxis BioScience
HQ: United States
Website
- Description: Provider of next-generation therapeutics and core technologies for the treatment of cancer and other critical illnesses; engages in the discovery, development, and delivery of therapies, including Abraxane, a nanoparticle chemotherapeutic compound.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Abraxis BioScience company profile →
Magnolia Medical
HQ: United States
Website
- Description: Provider of blood culture contamination reduction solutions, including Steripath Initial Specimen Diversion Device and Steripath Micro to divert and sequester initial blood draws, the Mission Control educational platform offering best-practice collection training, and a clinical performance guarantee of at least 50% contamination reduction or money back.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Magnolia Medical company profile →
Affinergy
HQ: United States
Website
- Description: Provider of application-specific coatings and medical devices for orthopedic and cardiovascular markets; diagnostic assays including an ApoL1 G0 variant blood test to inform kidney transplantation, therapeutic drug monitoring for Tacrolimus, Vancomycin and Hepcidin, and immune profile diagnostics for autoimmune diseases; plus peptide and antibody display services to identify interactions and binding affinities, and epitope mapping.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Affinergy company profile →
IntelliCyt
HQ: United States
Website
- Description: Provider of high-throughput cell and bead-based screening solutions for use throughout the life sciences, leveraging proprietary technologies to deliver instrumentation, reagent kits, and software that increase the speed and reduce the cost of detecting and measuring cells.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full IntelliCyt company profile →
ARTMS
HQ: Canada
Website
- Description: Provider of cyclotron-based technology for decentralized, local production of diagnostic imaging isotopes and purified radiopharmaceuticals. Offers the QUANTM Irradiation System (QIS) and QUANTM platforms for gallium-68, technetium-99m, zirconium-89, and copper-64, featuring automatic 2-way pneumatic transfer, a compact solid target station, and complete solid target processing solutions for PET and other clinical applications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ARTMS company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Alamar Biosciences
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Alamar Biosciences
2.2 - Growth funds investing in similar companies to Alamar Biosciences
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Alamar Biosciences
4.2 - Public trading comparable groups for Alamar Biosciences
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →